Political lessons from the global HIV/AIDS response to inform a rapid noncommunicable disease response

AIDS

Volumn 26, Issue 9, 2012, Pages 1171-1173

  Mills, Edward J ^a   Ford, Nathan ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Medecins Sans Frontiers   (Switzerland)

Author keywords

HIV AIDS; noncommunicable diseases; task shifting

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; CHRONIC DISEASE; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; POLITICS; WORLD HEALTH;

EID: 84861528216     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834f3319     Document Type: Note

References (20)

1. Bloom DE, Chisholm D, Jane-Llopis E, Prettner K, Stein A, Feigl A. From burden to 'best buys': reducing the economic impact of non-communicable diseases in low and middle-income countries. Paper number 75. Working Paper Series; 2011. http://www.hsph.harvard.edu/pgda/WorkingPapers/2011/PGDA-WP-75.pdf.
2. Piot P. Global AIDS epidemic: time to turn the tide. Science 2000; 288:2176-2178.
3. Ford N, Calmy A, Mills EJ. The first decade of antiretroviral therapy in Africa. Global Health 2011; 7:33.
4. Gupta R, Irwin A, Raviglione MC, Kim JY. Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis. Lancet 2004; 363:320-324.
5. Feldbaum H, Lee K, Michaud J. Global health and foreign policy. Epidemiol Rev 2010; 32:82-92.
6. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358:410-414.
7. MarsdenDL, Spratt NJ,Walker R, Barker D, Attia J, Pollack M, et al. Trends in stroke attack rates andcase fatality in theHunter region, Australia 1996-2008. Cerebrovasc Dis 2010; 30:500-507.
8. Cohen D. The final declaration for the UN summit on NCDs. BMJ Blog; 2011. http://blogsbmjcom/bmj/2011/09/09/deborahcohen-the-final-declaration-for-the- un-summit-on-ncds-2/.
9. Ford N, 'tHoen E,McKee M. Trade concernsmust not be allowed to set the public health agenda. Lancet 2003; 361:71-72.
10. Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009; 373:1341-1351.
11. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377:31-41.
12. Muldoon KA, Galway LP, Nakajima M, Kanters S, Hogg RS, Bendavid E, et al. Health system determinants of infant, child and maternal mortality: a cross-sectional study of UN member countries. Global Health 2011; 7:42.
13. Ford N, Mills EJ, Simplified ART. delivery models are needed for the next phase of scale up. PLoS Med 2011; 8:e1001060.
14. Mugyenyi P, Walker AS, Hakim J, Munderi P, Gibb DM, Kityo C, et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised noninferiority trial. Lancet 2010; 375:123-131.
15. Bourbeau J, Nault D. Self-management strategies in chronic obstructive pulmonary disease. Clin Chest Med 2007; 28:617-628; vii.
16. Davies NJ, Batehup L. Towards a personalised approach to aftercare: a review of cancer follow-up in the UK. J Cancer Surviv 2011; 5:142-151.
17. Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 11:942-951.
18. Attaran A, Freeberg K, Hirsch M. Dear wrong on AIDS. The Washington Post 15 June 2001. A33.
19. Mills EJ,Nachega JB, Buchan I,Orbinski J, Attaran A, SinghS, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296: 679-690.
20. Usher AD. Donors continue to hold back support from Global Fund. Lancet 2011; 378:471-472.